Rader reasoned that the expedited generic drug approval process created by the Act required drug testing by the generic manufacturer prior to patent expiration and that § 271 (e) (1) thus covers only ...
On Friday, the Food and Drug Administration announced a new pilot prioritization program for the review of abbreviated new drug applications that aims to spur and reward investment in U.S. drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback